$9.84
0.212.13%
Last update: Nov 9, 12:07 PM
Telix Pharmaceuticals Ltd
TLXNASDAQ
The average analyst price target for Telix Pharmaceuticals is $21.20, 115.6% above the current price. Of 5 analysts, 4 rate it Buy and 1 Hold. Targets range from $20 to $22. The latest change came on Jul 7, 2026, when Citigroup lowered its price target on Telix Pharmaceuticals from $22.50 to $22 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
